SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-025823
Filing Date
2023-05-19
Accepted
2023-05-19 21:25:17
Documents
2
Period of Report
2023-05-16

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1458
2 EXHIBIT 24 brhc20053227_ex24.htm EX-24 9929
  Complete submission text file 0001140361-23-025823.txt   13028
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Issuer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Dunn William H. Jr. (Reporting) CIK: 0001977655 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 23942242